In the week of March 18, 2012, Avance Biosciences entered a Master Service Agreement (MSA) with a global leader in custom biologics manufacturing. Based on this agreement, Avance Biosciences will provide its GMP level Cell Bank Characterization services, including DNA Sequencing, qPCR, Southern blot and other molecular biological methods, to characterize the Master Cell Bank (MCB), Working Cell Bank (WCB), and End of Production Cells (EOPC) submitted by the client.
“This is the first such agreement that we have signed with a key global biologics manufacturer”, said Dr. Xuening (James) Huang, Co-founder and general manager of Avance Biosciences Inc. “We expect more such agreements to be signed in the next few months as we continue our discussions with other pharmaceutical and biopharmaceutical companies to establish preferred vendor status for their cell bank characterization needs.”
“The efforts we have made to establish an industry-leading quality system started to pay dividends the beginning of this year when we began our marketing push for our GMP Cell Bank Characterization services”, stated Dr. David Wall, Vice President of Quality of Avance Biosciences. “In the past several months, our Quality Unit has received a significantly increased number of inquiries from potential clients regarding our quality system. We are happy that the feedback we received is nothing but positive, which is very encouraging”.
About Avance Biosciences
Avance offers cGMP/GLP compliant biological testing services in support of drug development and manufacturing. Its leading scientists have designed, validated, and tested thousands of assays under cGMP/GLP regulations for the FDA, EPA, and European and Japanese regulatory agencies. Avance’s team has extensive knowledge and experience working with scientists, QA/QC professionals and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.
9770 West Little York Road
Houston, TX 77040 USA